Verition Fund Management LLC
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 1454027
GREENWICH, CT
Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$937,069
-$1,639,785 QoQ
Shares Held
34,732
-63.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#116
of 224 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Derivatives in MLYS
reported options exposure · as of Mar 31, 2026CallValue
$677,250
CallShares
25,000
PutValue
$2,709,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names. MLYS ranks #30 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in MLYS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $937,069 | 34,732 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,576,854 | 95,122 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $2,709,000 | 100,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $677,250 | 25,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $1,814,500 | 50,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $3,042,553 | 83,840 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $700,116 | 18,463 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $331,341 | 27,361 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $245,150 | 20,953 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||